Skip to main content

New anticoagulants--the path from discovery to clinical practice.

Publication ,  Journal Article
Lohrmann, J; Becker, RC
Published in: The New England journal of medicine
June 2008

Duke Scholars

Published In

The New England journal of medicine

DOI

EISSN

1533-4406

ISSN

0028-4793

Publication Date

June 2008

Volume

358

Issue

26

Start / End Page

2827 / 2829

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Thiophenes
  • Rivaroxaban
  • Morpholines
  • Humans
  • General & Internal Medicine
  • Factor Xa Inhibitors
  • Enoxaparin
  • Anticoagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lohrmann, J., & Becker, R. C. (2008). New anticoagulants--the path from discovery to clinical practice. The New England Journal of Medicine, 358(26), 2827–2829. https://doi.org/10.1056/nejme0804291
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.The New England Journal of Medicine 358, no. 26 (June 2008): 2827–29. https://doi.org/10.1056/nejme0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. The New England journal of medicine. 2008 Jun;358(26):2827–9.
Lohrmann, Jens, and Richard C. Becker. “New anticoagulants--the path from discovery to clinical practice.The New England Journal of Medicine, vol. 358, no. 26, June 2008, pp. 2827–29. Epmc, doi:10.1056/nejme0804291.
Lohrmann J, Becker RC. New anticoagulants--the path from discovery to clinical practice. The New England journal of medicine. 2008 Jun;358(26):2827–2829.

Published In

The New England journal of medicine

DOI

EISSN

1533-4406

ISSN

0028-4793

Publication Date

June 2008

Volume

358

Issue

26

Start / End Page

2827 / 2829

Related Subject Headings

  • Venous Thrombosis
  • Venous Thromboembolism
  • Thiophenes
  • Rivaroxaban
  • Morpholines
  • Humans
  • General & Internal Medicine
  • Factor Xa Inhibitors
  • Enoxaparin
  • Anticoagulants